Healthcare & Medical Devices Global On demand · 24-48h

Global Viral Sample Preservation Solution Market Strategic Research Report

Global Viral Sample Preservation Solution Market Strategic R…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Viral Sample Preservation Solution Market
$2032025
5.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Inactivated, Non-inactivated

By Application: Hospital, Clinic, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, Longhorn Vaccines and Diagnostics, EKF Diagnostics Holdings, Biosigma, BIOBASE, BD, Aptaca, Orient Gene, Mole Bioscience, Biocomma, Beijing Hanbaihan Medical, Darui Biotech, Hangzhou LifeReal Biotechnology, Copan Diagnostics, BioServUK, Guangdong Hybribio Biotech, Haimen Shengbang Laboratory Equipment, Longsee Biomedical, Hangzhou Jiuyang Biotechnology, Jifan Biotechnology (Beijing), Puritan Medical Products, Cardinal Health, Medline Industries, Shandong Chengwu Medical Products Factory

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 165 pages
Market size 2025
$203
Million USD
Forecast CAGR
5.1%
2025-2032
Forecast 2032
$287.6
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Viral Sample Preservation Solution market size is predicted to grow from US$ 203 million in 2025 to US$ 288 million in 2032; it is expected to grow at a CAGR of 5.1% from 2026 to 2032.

Viral Sample Preservation Solution is an integrated technical system combining specialized preservatives, sterile containers, and standardized operating procedures, designed to maintain the integrity of viral particles (viability) or nucleic acids (RNA/DNA) during collection, transport, and storage. It includes inactivated and non-inactivated types, adapts to different temperature conditions (ambient, low-temperature, ultra-low-temperature), and prevents sample degradation or contamination, providing reliable sample support for viral detection, scientific research, and vaccine development.

In 2025, global Viral Sample Preservation Solution production reached approximately 52 million units, with an average global market price of around US$ 4 per unit.

The Viral Sample Preservation Solution market is experiencing significant growth driven by several key factors: Market Drivers: Rising burden of infectious diseases: Increasing prevalence of various viral diseases, including COVID-19, influenza, and emerging viral threats, fuels demand for efficient sample preservation for diagnostics and research. Expanding laboratory testing and research activities: Growing focus on public health surveillance, vaccine development, and antiviral research necessitates reliable viral sample preservation. Focus on biosafety and sample integrity: Concerns about sample degradation and potential loss of viral RNA/DNA during transport and storage drive demand for high-quality preservation solutions. Technological advancements: Development of novel stabilization technologies, inactivation methods, and combination solutions with enhanced efficacy and broader viral compatibility. Increasing awareness and adoption in various settings: Healthcare facilities, research laboratories, and even field workers are recognizing the benefits of using preservation solutions for improved sample handling and testing accuracy. Market Challenges: Regulation and compliance: Stringent regulations governing viral sample handling and transportation require manufacturers to ensure solution compliance and safety. Competition and price sensitivity: Wide range of available solutions creates price competition, influencing purchasing decisions. Developing markets: Limited healthcare infrastructure and awareness in some regions pose challenges for market penetration. Overall, the Viral Sample Preservation Solution market presents promising opportunities for manufacturers, distributors, and research institutions. Focusing on addressing regulatory challenges, developing novel solutions, and providing cost-effective options will be crucial to ensuring the market's sustainable growth and contribution to global health initiatives.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Viral Sample Preservation Solution market?

What factors are driving Viral Sample Preservation Solution market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Viral Sample Preservation Solution market opportunities vary by end market size?

How does Viral Sample Preservation Solution break out by Type, by Application?

This report presents a comprehensive overview of the global Viral Sample Preservation Solution market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Inactivated
  • Non-inactivated

Segment by Preservation Temperature Requirement

  • Ambient Temperature Preservation Solution
  • Low-Temperature Preservation Solution
  • Ultra-Low Temperature Preservation Solution

Segment by Target Sample Type

  • Swab Sample Preservation Solution
  • Tissue Sample Preservation Solution
  • Others

Segment by Application

  • Hospital
  • Clinic
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Viral Sample Preservation Solution market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Viral Sample Preservation Solution Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$203
2025
Forecast
$287.6
2032
CAGR
5.1%
2025–2032
Regions
5
global
Key companies
Thermo Fisher ScientificLonghorn Vaccines and DiagnosticsEKF Diagnostics HoldingsBiosigmaBIOBASEBDAptacaOrient Gene
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
InactivatedNon-inactivated
By Application
HospitalClinicOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Inactivated
  • 3.1.3 Non-inactivated
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Longhorn Vaccines and Diagnostics
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 EKF Diagnostics Holdings
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Biosigma
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 BIOBASE
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 BD
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Aptaca
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Orient Gene
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Mole Bioscience
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Biocomma
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Beijing Hanbaihan Medical
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Darui Biotech
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Hangzhou LifeReal Biotechnology
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Copan Diagnostics
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 BioServUK
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Guangdong Hybribio Biotech
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Haimen Shengbang Laboratory Equipment
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Longsee Biomedical
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Hangzhou Jiuyang Biotechnology
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Jifan Biotechnology (Beijing)
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Puritan Medical Products
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Cardinal Health
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Medline Industries
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Shandong Chengwu Medical Products Factory
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Viral Sample Preservation Solution market?
The global Viral Sample Preservation Solution market is estimated at US$ 203 million in 2025 (base year) and is projected to reach US$ 288 million by 2032.
How fast is the Viral Sample Preservation Solution market expected to grow?
The market is expected to grow at a CAGR of 5.1% from 2026 to 2032, expanding from US$ 203 million in 2025 to US$ 288 million in 2032, roughly 1.4 times its base-year value.
What does the Viral Sample Preservation Solution market cover?
Viral Sample Preservation Solution is an integrated technical system combining specialized preservatives, sterile containers, and standardized operating procedures, designed to maintain the integrity of viral particles (viability) or nucleic acids (RNA/DNA) during collection, transport, and storage.
What are the main segments of the Viral Sample Preservation Solution market by type?
By type, the market is segmented into Inactivated and Non-inactivated.
Which applications drive demand in the Viral Sample Preservation Solution market?
Key applications covered include Hospital, Clinic and Others.
Who are the key players in the Viral Sample Preservation Solution market?
Key players profiled include Thermo Fisher Scientific, Longhorn Vaccines and Diagnostics, EKF Diagnostics Holdings, Biosigma, BIOBASE, BD, Aptaca and Orient Gene, among 24 companies covered in total.
Which regions and countries are covered for Viral Sample Preservation Solution?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Viral Sample Preservation Solution market?
The Viral Sample Preservation Solution market is experiencing significant growth driven by several key factors: Market Drivers: Rising burden of infectious diseases: Increasing prevalence of various viral diseases, including COVID-19, influenza, and emerging viral threats, fuels demand for efficient sample preservation for diagnostics and research.
What challenges does the Viral Sample Preservation Solution market face?
Market Challenges: Regulation and compliance: Stringent regulations governing viral sample handling and transportation require manufacturers to ensure solution compliance and safety.
Who should buy the Viral Sample Preservation Solution market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Clinic and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Viral Sample Preservation Solution market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.